Mary K. Moreland - 28 Apr 2026 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Reporting relationship: EXECUTIVE VICE PRESIDENT
Issuer ticker: ABT
Reported as of: 28 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Apr 2026, 17:09:00 UTC
Prior SEC filing: 03 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mary K. Moreland by Jessica H. Paik, Attorney-in-Fact

Key filing fact

Mary K. Moreland filed Form 4 for ABBOTT LABORATORIES (ABT) on 29 Apr 2026.

Key facts

This page summarizes Mary K. Moreland's Form 4 filing for ABBOTT LABORATORIES (ABT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 29 Apr 2026, 17:09.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001783147 Primary reporting owner

Shares, units, or other non-derivative securities reported in this filing.

ABT transaction

Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities

ABT holding

No transaction description listed

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Balance in the Abbott Laboratories Stock Retirement Trust as of April 28, 2026.